Holen Sie sich die Stockscreener-App
9.62
4.11%
0.38
Handel nachbörslich:
9.62
Schlusskurs vom Vortag:
$9.24
Offen:
$9.43
24-Stunden-Volumen:
6,984
Relative Volume:
0.33
Marktkapitalisierung:
$834.13M
Einnahmen:
$213.45M
Nettoeinkommen (Verlust:
$-72.46M
KGV:
-9.682
EPS:
-0.9936
Netto-Cashflow:
$-47.28M
1W Leistung:
-1.54%
1M Leistung:
+14.39%
6M Leistung:
+25.26%
1J Leistung:
+98.35%
1-Tages-Spanne:
$9.40
$10.09
1-Wochen-Bereich:
$9.20
$10.32
52-Wochen-Spanne:
$4.845
$12.25
Valneva Se Adr Stock (VALN) Company Profile
Vergleichen Sie VALN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VALN
Valneva Se Adr
|
9.62 | 801.18M | 213.45M | -72.46M | -47.28M | -0.9936 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Valneva Se Adr Stock (VALN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-08-03 | Eingeleitet | H.C. Wainwright | Buy |
Valneva Se Adr Aktie (VALN) Neueste Nachrichten
Valneva (NASDAQ:VALN) Stock Price Down 5.6%Here's What Happened - MarketBeat
Valneva (NASDAQ:VALN) Shares Gap DownTime to Sell? - MarketBeat
Valneva stock falls after withdrawing chikungunya vaccine BLA in U.S. By Investing.com - Investing.com Nigeria
Valneva stock falls after withdrawing chikungunya vaccine BLA in U.S. - Investing.com
Valneva (NASDAQ:VALN) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Valneva (NASDAQ:VALN) Shares Gap UpWhat's Next? - MarketBeat
VLA Stock Price and Chart — EURONEXT:VLA - TradingView — Track All Markets
Valneva (NASDAQ:VALN) Shares Up 4.9%What's Next? - MarketBeat
Valneva (NASDAQ:VALN) Stock Price Down 4.6%Time to Sell? - MarketBeat
Valneva (NASDAQ:VALN) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Frazier Life Sciences Management L.P. Makes New Investment in Valneva SE Sponsored ADR $VALN - MarketBeat
Valneva stock rises after positive final Phase 2 results for chikungunya vaccine - Investing.com India
VALNEVA Declaration of shares and voting rights: November 30, 2025 - GlobeNewswire Inc.
Valneva (NASDAQ:VALN) Stock Price Down 3.1%What's Next? - MarketBeat
Valneva stock rises after positive Lyme disease vaccine booster data - Investing.com
Valneva SE earnings beat by $0.02, revenue fell short of estimates - Investing.com
Valneva (VALN) Projected to Post Earnings on Thursday - MarketBeat
Disney, Brookfield, Nu Holdings and more set to report earnings Thursday - Investing.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SEVALN - 2822news.com
Free cash flow per share of Valneva SE Sponsored ADR – LS:A3CPD1 - TradingView
Valneva SE Sponsored ADR (NASDAQ:VALN) Short Interest Update - MarketBeat
Valneva's (VALN) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Valneva (NASDAQ:VALN) Trading Down 0.8%Time to Sell? - MarketBeat
Valneva (NASDAQ:VALN) Trading Down 0.8% – Time to Sell? - Defense World
Valneva (NASDAQ:VALN) Stock Price Down 4.9%Here's Why - MarketBeat
Kepler Capital Sticks to Its Buy Rating for Valneva (0OB3) - Barchart.com
Valneva–Aktie: Finanzierung gesichert, Erwartungen gesenkt! - Finanztrends
Valneva stock falls after FDA suspension forces guidance cut - Investing.com
Valneva’s Ixchiq shows 95% 4-year antibody persistence, shares up 10% - Investing.com
VALNEVA ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Finanzdaten der Valneva Se Adr-Aktie (VALN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.09%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):